Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-01-16
2007-01-16
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C562S008000
Reexamination Certificate
active
10481485
ABSTRACT:
The invention encompasses the novel class of compounds represented by the formula below, which are inhibitors of the PTP-1B enzyme.The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing PTP-1B mediated diseases, including diabetes.
REFERENCES:
patent: 6448429 (2002-09-01), Leblanc et al.
patent: 6465444 (2002-10-01), Bayly et al.
patent: 6486141 (2002-11-01), Lau et al.
patent: 6583126 (2003-06-01), Leblanc et al.
patent: 6716825 (2004-04-01), Hostetler et al.
patent: 7001896 (2006-02-01), Yin et al.
patent: WO 0017211 (2000-03-01), None
patent: WO 0146206 (2001-06-01), None
patent: WO 0170753 (2001-09-01), None
Dufresne Claude
Lau Cheuk K.
Leblanc Yves
Li Chun Sing
Roy Patrick
Lambkin Deborah C.
McGinnus James L.
Merck Frosst Canada & Co.
Winokur Melvin
LandOfFree
Aryldifluoromethylphosphonic acids for treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryldifluoromethylphosphonic acids for treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryldifluoromethylphosphonic acids for treatment of diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3749250